Slocum, Gordon & Co’s Thermo Fisher Scientific TMO Stock Holding History

Slocum, Gordon & Co’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-424	Closed	-$246K	–	68
2025 Q4	$246K	Sell	424 -125	-23%	-$70.7K	0.18%	54
2025 Q3	$266K	Hold	549	–	–	0.21%	48
2025 Q2	$223K	Hold	549	–	–	0.18%	52
2025 Q1	$273K	Hold	549	–	–	0.2%	47
2024 Q4	$286K	Sell	549 -25	-4%	-$13.7K	0.23%	46
2024 Q3	$355K	Sell	574 -40	-7%	-$23.7K	0.14%	47
2024 Q2	$340K	Hold	614	–	–	0.25%	42
2024 Q1	$357K	Sell	614 -50	-8%	-$28.1K	0.26%	41
2023 Q4	$352K	Hold	664	–	–	0.31%	39
2023 Q3	$336K	Buy	+664	New	+$354K	0.29%	41
2023 Q2	–	Sell	-664	Closed	-$383K	–	153
2023 Q1	$383K	Hold	664	–	–	0.32%	37
2022 Q4	$366K	Buy	+664	New	+$352K	0.24%	40

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Slocum, Gordon & Co's TMO Position: Q1 2026 in Review

Slocum, Gordon & Co sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 424 shares — an estimated $246K sold.

Slocum, Gordon & Co first reported a position in TMO in Q4 2022 and held it in 12 quarters. The position peaked at $383K in Q1 2023. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Slocum, Gordon & Co reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Slocum, Gordon & Co sold 424 Thermo Fisher Scientific shares in Q1 2026, an estimated $246K.
Slocum, Gordon & Co first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 12 quarters.
Slocum, Gordon & Co's Thermo Fisher Scientific position peaked at $383K in Q1 2023.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Slocum, Gordon & Co's 13F filing for Q1 2026, filed 15 Apr 2026.